"We are MercyOne: a connected system of health care facilities and services dedicated to helping you live your best life."

During the past decade, Mercy Cancer Center at Mercy Medical Center - Des Moines conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 79 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 11 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Cancer Center at Mercy Medical Center - Des Moines" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 83 trials, followed by "Eastern Cooperative Oncology Group" with 21 trials sponsored, "SWOG Cancer Research Network" with 12 trials sponsored, "Radiation Therapy Oncology Group" with 7 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Cancer Center at Mercy Medical Center - Des Moines" #1 collaborator was "National Cancer Institute (NCI)" with 137 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "Eastern Cooperative Oncology Group" with 6 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Cancer Center at Mercy Medical Center - Des Moines" are "Breast Cancer" (33 trials), "Lung Cancer" (23 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (13 trials), "Lymphoma" (11 trials) and "Metastatic Cancer" (10 trials). Many other conditions were trialed in "Mercy Cancer Center at Mercy Medical Center - Des Moines" in a lesser frequency.

Most popular intervention types in "Mercy Cancer Center at Mercy Medical Center - Des Moines" are "Drug" (113 trials), "Biological" (47 trials), "Other" (41 trials), "Radiation" (28 trials) and "Procedure" (15 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (29 trials), "carboplatin" (16 trials), "radiation therapy" (16 trials), "bevacizumab" (14 trials) and "paclitaxel" (12 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Cancer Center at Mercy Medical Center - Des Moines" are 114 trials for "All" genders, 19 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Cancer Center at Mercy Medical Center - Des Moines". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 119 completed trials in Mercy Cancer Center at Mercy Medical Center - Des Moines, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Cancer Center at Mercy Medical Center - Des Moines, 5 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".